Trial
NCT05740007
A Phase 2 Study of IW-3300 for the Treatment of Bladder Pain in Subjects With Interstitial Cystitis/Bladder Pain Syndrome
Phase IITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Ironwood Pharmaceuticals, Inc.
Collaborators
—
Condition
Interstitial Cystitis
Intervention
IW-3300 rectal foam
Why stopped
Business decision
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2025-02-28